AUTH/3332/4/20: Anonymous v Sobi — unsolicited MSL “making contact” email during COVID-19 (No breach)

📅 2020 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3332/4/20
PartiesAnonymous v Swedish Orphan Biovitrum Ltd (Sobi)
IssueUnsolicited email sent by an MSL to an NHS email address during COVID-19; alleged inappropriate contact/promotional intent
ComplainantAnonymous, non-contactable individual (on behalf of a hospital haematology team)
MaterialEmail(s) using a “Making contact – from Sobi UK&ROI medical team” template; Sobi provided redacted copies of 17 emails
Key contextCOVID-19 pressures; Sobi internal guidance to respect trust restrictions and keep communications non-promotional
Applicable Code year2019
Clauses considered2, 9.1, 15.2, 15.9
DecisionNo breach
Complaint received18 April 2020
Case completed26 November 2020
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable complainant (on behalf of a hospital haematology team) alleged an unsolicited email from a Sobi medical science liaison (MSL) to an NHS email address was inappropriate during COVID-19 pressures.
  • The complainant believed the email was sent to secure an interaction/meeting and amounted to promotion of the MSL’s “product and services”, adding burden to the team.
  • The complainant did not provide a copy of the email received, nor the “clear guidance” they said existed that HCPs should not be contacted.
  • Sobi said the MSL used an approved, non-promotional “making contact” template to send personalised emails to 17 health professionals in the relevant geographical area, offering medical/scientific support while working from home.
  • Sobi’s internal briefings (12 March and 26 March 2020) instructed staff to respect trust restrictions, ensure recipients were permitted (on CRM), and keep messages short, professional, respectful, accurate and non-promotional.
  • The template included supportive wording and offered to answer medical/scientific questions; the MSL’s emails closely mirrored it and included “Hopefully we can meet in the future”.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel found no evidence the email was inappropriate, promotional, or caused inconvenience as alleged.
  • The Panel considered Sobi’s briefing and template did not advocate conduct likely to lead to a breach.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training